RTOG0617 to Externally Validate Blood Cell ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Both Tumor and Normal Tissue for Individualized Dose Prescription

Authors :: Weili Wang
Robert MacRae
Samir Narayan
V.S. Kavadi
F.M. Kong
Jeffrey A. Bogart
Jeffrey D. Bradley
B. Lu
Elizabeth Gore
G.M. Cannon
C.D. Koprowski
JianYue Jin
J. Rothman
Yolanda I. Garces
James W. Welsh
R. Gaur
Chen Hu
Mitchell Machtay
Cliff G. Robinson
Source :: International Journal of Radiation Oncology*Biology*Physics. 108:S2
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Cancer Research
Radiation
business.industry
Normal tissue
Dose prescription
Blood cell
medicine.anatomical_structure
Oncology
Genotype
Cancer research
medicine
Biomarker (medicine)
Radiology, Nuclear Medicine and imaging
Radiosensitivity
ERCC1
business

Tools